CELL SIGNALING TECHNOLOGY search Cell Signaling Technology NFKB1 products
includes other brands or spellings
|
| ih | | Cell Signaling Technology, Inc NFKB1 antibody was tested in immunohistochemistry by HPA (CAB004031) . |
| wb | | New England Biolabs anti-IκB antibody was used in western blot to study the role for the innate immune signaling molecule IRAK-4 in T cell
activation. |
ROCKLAND search Rockland NFKB1 products
|
| emsa, wb | | Rockland Immunochemicals rabbit affinity-purified polyclonal antibody raised against NF- kB (p50) was used in EMSA to study the transcriptional activition of JFC1 by nuclear factor-kB and its regulation by tumour necrosis factor a in prostate carcinoma cells. |
| emsa | | Rockland rabbit polyclonal anti–NF-kappaB p50 antibody was used in EMSA to study the roles for AP-1 and C/EBPβ in the regulation of inducible granulysin gene expression in a human monocytic cell line THP-1. |
| emsa | | Rockland rabbit polyclonal anti-NF-kappaB p50 antibody was used in EMSA to study the role for protease-activated receptor 2 in serratia marcescens serralysin induced inflammatory responses in human cell lines. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology NFKB1 products
includes other brands or spellings
|
| chip, emsa, ip, wb | | Santa Cruz anti-p105/p50 antibody was used in Western blot, Immunoprecipitation, EMSA and ChIP assay to study the role of NF-κB p50 and Bcl-3 in LMP1-mediated upregulation of EGFR in human cervical carcinoma cells. |
| chip, wb | | Santa Cruz Biotechnology anti-p50 antibody was used in human fetal type II cells and in western blot, ChIP assay to study the effects of oxygen on cyclic AMP and interleukin-1 stimulation of surfactant protein A gene expression. |
| emsa, wb | | Santa Cruz anti-p50 antibody(H-119) was used in western blot and EMSA to study the role for protein methyltransferase 2 in inhibiting NF-κB function and promoting apoptosis in human kidney cell line 293. |
| emsa, wb | | Santa Cruz Biotechnology anti-p65 antibody(H-119) was used in western blot and EMSA to study the role for estrogen withdrawal-induced NF-κB activity and Bcl-3 expression in growth and hormone independence in human breast cancer cells. |
| emsa, wb | | Santa Cruz anti-NF-kappaB1 antibody(which recognizes p105 and p50) was used in western blot and EMSA to study the effect of attenuated poxvirus vector NYVAC on apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells. |
| emsa, wb | | Santa Cruz Biotechnology anti-NF-kappaB p50 antibody(SC-114 X) and anti-NF-kappaB p50 antibody(SC-1190) were respectively used in EMSA and western blot to study the role of NF-kappaB in prostate cancer progression in human cells. |
| emsa | | Santa Cruz Biotechnology NF-{kappa}B1 [p50/p105] antibody was used in EMSA to study RANTES expression regulation by plasma membrane CFTR. |
| emsa | | Santa Cruz anti-p65 subunit of NF-kappaB antibody was used in EMSA to study the HSP27 as a ubiquitin-binding protein involved in I-kappaB alpha proteasomal degradation. |
| emsa | | Santa Cruz Biotechnology Inc anti-p50 antibody was used in fresh frozen tumor and nontumorous liver tissues from human and in EMSA to study the NF-κB activation, uPA up-regulation, and hepatitis B viral X protein (HBx) expression in human hepatocellular carcinoma (HCC) and their clinicopathological significance. |
| emsa | | Santa Cruz anti-p50 antibody was used in EMSA to study the effect of transforming growth factor- 1 (TGF- 1) on human type II collagen gene expression in articular chondrocytes and the relationship of it with Sp3/Sp1 ratio. |
| emsa | | Santa Cruz Biotechnology NF-kappa-B antibody was used in emsa to determine the effects of A3AR modulation on mortality and hepatic and renal dysfunction in a murine model of sepsis. |
| emsa | | Santa Cruz rabbit polyclonal anti-p50 antibody(sc-7178X) was used in EMSA to study the role for the effect of human papillomavirus Type 16 E6 on NF-κB activation and cIAP-2 expression in protecting from apoptosis in primary human airway epithelial cells. |
| emsa | | Santa Cruz Biotechnology anti-p50 antibody was used in EMSA to study the role for IL-1 receptor-associated kinase 1 in latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation in human I1A 293 cells. |
| emsa | | Santa Cruz Biotechnology polyclonal anti-p50 antibody was used in EMSA to study the Stat3 expression, localization, and activity in alcoholic liver disease (ALD) in humans. |
| ih | | Santa Cruz goat polyclonal (sc-1191) antibody was used in immunohistochemistry to study NF-kappaB in human diabetic nephropathy. |
| ih | | Santa Cruz Biotechnology rabbit polyclonal anti-p50 antibody(H-119) was used in immunohistochemistry to study the role for activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammation and extracellular matrix degradation in inflammatory acne lesions in vivo in skin cryosections from patients. |
| ip, wb | | Santa Cruz Biotechnology anti-p50/p105 antibody sc-114X was used in immunoprecipitation and western blot to study the role of RelB serine 368 for dimerization and p100 stabilization. |
| ip, wb | | Santa Cruz Biotechnology anti-p50 antibody was used in western blot and immunoprecipitation to detect p50 in Jurkat cells and HeLa cells. |
| ip, wb | | Santa Cruz rabbit anti-NF-kappaB1 p50 antibody(which recognizes both p105 and p50) was used in immunoprecipitation and western blot to study the role for IKKbeta in mediating both processing and degradation of p105 in COS-7 cells with human p105. |
| ip, wb | | Santa Cruz anti-NF-kappaB p50 antibody(C-19) was used in western blot and immunoprecipitation to study the effect of upregulation of HMG1 on melanoma inhibitory activity expression in malignant melanoma cells. |
| ip, wb | | Santa Cruz Biotechnology anti-p50 antibody was used in western blot and immunoprecipitation to study the role for NF-kappaB binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells. |
| ip | | Santa Cruz Biotechnology anti-p50 antibody(#sc114x) was used in immunoprecipitation to study the role for myotrophin/V-1 in modulating the levels of activated NF B dimers in human HeLa cells. |
| wb | | Santa Cruz Biotechnology NF-kB antibody was used in western blot to study the survival effect of tumour necrosis factor-alpha in human neutrophils. |
| wb | | Santa Cruz Biotechnology anti-NF-kappa B monoclonal antibody was used in western blot to study the CDX1 as an important molecular mediator of Barrett's metaplasia. |
| wb | | Santa Cruz Biotechnology monoclonal anti-p50 antibody was used in Western blot to study the biological function of nerve growth factor in the regulation of dopamine D2 receptor expression. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal anti-p50 antibody was used in western blot to study the identification and characterization of a novel ZU5 and death domain-containing protein designated ZUD in human 293 cells. |
| wb | | Santa Cruz anti-p105/p50 antibody(E10) was used in western blot to study the potential binding partners to Cot and their region of association by separating proteins that were pulled-down with various Cot constructs following immunoprecipiation in human HEK293 cells and Hela cells. |
| wb | | Santa Cruz Biotechnology anti-NF-kappaB p65 polyclonal antibody (sc109) was used in western blot to study GR-mediated transrepression of the transcription factors AP-1 and NF-B through Trip6. |
ABCAM search Abcam NFKB1 products
includes other brands or spellings
|
| emsa | | Abcam anti-NF-kappaB (p50) antibody was used in EMSA to study a new, general, inexpensive FRET-based approach for assaying sequence-specific DNA-binding proteins in human HeLa cell. |
| ih | | Abcam NF-kappaB antibody was used in immunohistochemistry to demonstrate that MALT1 gene rearrangements are absent or rare in primary breast MALT lymphoma. |
MILLIPORE search Millipore NFKB1 products
includes other brands or spellings
|
| wb | | Chemicon rabbit polyclonal antibody against NFkappaB was used in western blot to compare the expression of A3 adenosine receptor in tumor versus normal cells. |
| wb | | Upstate anti-NF-kappaB p50 antibody was used in western blot to study the effect of H1 RNA polymerase III promoter-driven expression of an RNA aptamer on intracellular protein activity in human cells. |
INVITROGEN search Invitrogen NFKB1 products
includes other brands or spellings
|
| wb | | Zymed NFkappaB RelA p65 antibody was used in western blot to study intestinal epithelial barrier dysfunction by interferon gamma and tumor necrosis factor alpha. |
AUTOGENBIOCLEAR
|
| wb | | Autogenbioclear rabbit anti-mouse NF-kappaB (p50) antibody was used in western blot to study the effect of induction of polymorphonuclear leukocytes by avirulent salmonella enterica on protection of pigs and human against salmonellosis in human fetal intestinal epithelial INT 407 cells. |
BOEHRINGER MANNHEIM
|
| ih | | Boehringer Mannheim mouse monoclonal anti-NF-kappaB p65 (cat 1697838) antibody was used in immunohistochemistry to study NF-kappaB in human diabetic nephropathy. |
NANCY RICE
|
| ih | | Nancy Rice p105/p50 polyclonal antibody (PAb-1157) was used in immunohistochemistry to study the expression pattern of NFκB family members in human melanocytic cells of normal skin, benign intradermal naevus and metastatic melanoma tissues. |
ROCKLAND IMMUNOCHEMICALS
|
| emsa, wb | | Rockland Immunochemicals rabbit affinity-purified polyclonal antibody raised against NF- kB (p50) was used in EMSA to study the transcriptional activition of JFC1 by nuclear factor-kB and its regulation by tumour necrosis factor a in prostate carcinoma cells. |
Articles Reviewed |
| 1. Chiara Fiorentini et al. Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. 2002 |
| 2. Charlie D Chen et al. NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. 2002 |
| 3. Pascal Knuefermann et al. Myotrophin/V-1, a protein up-regulated in the failing human heart and in postnatal cerebellum, converts NFkappa B p50-p65 heterodimers to p50-p50 and p65-p65 homodimers. 2002 |
| 4. Sergio D Catz et al. JFC1 is transcriptionally activated by nuclear factor-kappaB and up-regulated by tumour necrosis factor alpha in prostate carcinoma cells. 2002 |
| 5. Christos Chadjichristos et al. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. 2002 |
| 6. Rosemary Kiernan et al. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. 2003 |
| 7. Yutaka Kida et al. Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1. 2002 |
| 8. Kim Estell et al. Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. 2003 |
| 9. Peter Stärkel et al. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans. 2003 |
| 10. N Foster et al. Rapid protection of gnotobiotic pigs against experimental salmonellosis following induction of polymorphonuclear leukocytes by avirulent Salmonella enterica. 2003 |
| 11. Ina Poser et al. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. 2003 |
| 12. Harald Jakob Maier et al. Critical role of RelB serine 368 for dimerization and p100 stabilization. 2003 |
| 13. Arnaud Parcellier et al. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. 2003 |
| 14. M A Christine Pratt et al. Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence. 2003 |
| 15. Shai Cohen et al. Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing. 2004 |
| 16. Jun Zhang et al. Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB. 2004 |
| 17. Susan E McNulty et al. Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. 2004 |
| 18. S R Walmsley et al. Characterization of the survival effect of tumour necrosis factor-alpha in human neutrophils. 2004 |
| 19. Chun-Fung Chan et al. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. 2004 |
| 20. Mary H Ritchie et al. A role for NF-kappa B binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells. 2004 |
| 21. Lea Madi et al. The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. 2004 |
| 22. Sergio Mezzano et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. 2004 |
| 23. Olivier Kassel et al. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters. 2004 |
| 24. Fengjun Wang et al. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. 2005 |
| 25. Jinke Wang et al. Exonuclease III protection assay with FRET probe for detecting DNA-binding proteins. 2005 |
| 26. N A C S Wong et al. CDX1 is an important molecular mediator of Barrett's metaplasia. 2005 |
| 27. Sewon Kang et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. 2005 |
| 28. Susana Guerra et al. Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells. 2006 |
| 29. Yoon-Jae Song et al. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation. 2006 |
| 30. Nobutaka Suzuki et al. A critical role for the innate immune signaling molecule IRAK-4 in T cell activation. 2006 |
| 31. Kazi Nazrul Islam et al. Permissive effects of oxygen on cyclic AMP and interleukin-1 stimulation of surfactant protein A gene expression are mediated by epigenetic mechanisms. 2006 |
| 32. Lakshmanan Ganesh et al. Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis. 2006 |
| 33. Michael A James et al. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. 2006 |
| 34. H Thomas Lee et al. A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. 2006 |
| 35. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 36. Jing Mi et al. H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. 2006 |
| 37. Sameer S Talwalkar et al. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. 2006 |
| 38. Yutaka Kida et al. Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2. 2007 |
| 39. Natalie J Thornburg et al. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes. 2007 |
| 40. Binhui Wu et al. Proteomics analysis of immunoprecipitated proteins associated with the oncogenic kinase cot. 2008 |